摘要 |
The invention relates to the use of adenosine compounds described by formula (I) and certain derivatives thereof for producing a medicine for the treatme nt of the insulin resistance syndrome and diabetes. In formula (I), K is N, NO, or CH; Q is CH2 or O; R6 is hydrogen, alkyl, allyl, 2-methallyl, 2-butenyl, or cycloalkyl; X is (a) or (b); E is O or S; Y is e.g. hydrogen, alkyl, aralkyl , aryl; n and p are independently 0, 1, 2 or 3 provided that n + p is at least 1; T is e.g. hydrogen, alkyl, acyl, thioacyl, halo, carboxyl; R1, R2 and R3 are independently H, alkyl, or cycloalkyl; A is hydrogen, alkyl, hydroxyalky l, alkoxyalkyl, or OR'; B is hydrogen, alkyl, hydroxyalkyl, alkoxyalkyl, or OR" ; R' and R" are e.g independently hydrogen, alkyl, aralkyl or carbamoyl.</SDOA B>
|
申请人 |
AVENTIS PHARMA DEUTSCHLAND GMBH |
发明人 |
MAGUIRE, MARTIN P.;MYERS, MICHAEL R.;JAEHNE, GERHARD;SPADE, ALFRED P.;EWING, WILLIAM R.;CHOI-SLEDESKI, YONG-MI;PAULS, HENRY W.;HERLING, ANDREAS |